Estado actual de la investigación en cirugía bariátrica

  1. A. Camacho-Ramírez 1
  2. M. Aguilar-Diosdado 1
  3. F. J. Campos Martínez 2
  4. J. Salas-Álvarez 2
  5. J. Falckenheiner-Soria 2
  6. A. Moreno-Arciniegas 3
  7. G. M. Pérez-Arana 4
  8. J. A. Prada-Oliveira 4
  1. 1 Hospital Universitario Puerta del Mar. Cádiz. INIBICA.
  2. 2 Hospital Universitario Puerto Real. Cádiz.
  3. 3 Hospital Universitario de Ceuta. Ceuta.
  4. 4 Departamento de Anatomía y Embriología Humana. Facultad de Medicina. Cádiz. INIBICA.
Cirugía Andaluza

ISSN: 2695-3811 1130-3212

Year of publication: 2019

Volume: 30

Issue: 4

Pages: 515-521

Type: Article

DOI: 10.37351/2019304.13 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

More publications in: Cirugía Andaluza


Research in medicine is the only tool the physician has, to improve and to change his activity. In this aspect, bariatric surgery is not different from the rest of the medical field. From the beginning to the present time, indications and addressings have been changing. Scientific societies with their organization and guidelines marking the general steps and direction of clinical performances, but also the research training. Over the last few years the amount and quality of papers have increased. This projection makes progress and innovation of new technologies possible, such as endoscopic techniques or the better indications for metabolic surgery. The research in bariatric surgery and its comorbidities is not only the outcome of the routine clinical practices. It is unavoidable their spreading to deeper and more complex fields as the knowledge of its mechanisms. The link between human and animal research is mandatory in order to ensure the progress in this surgical field.

Bibliographic References

  • Deitel, M. and J. Melissas, The origin of the word "bari". Obes Surg, 2005. 15(7): p. 1005-8.
  • Leroux, J.S., S. Moore, and L. Dube, Beyond the "I" in the obesity epidemic: a review of social relational and network interventions on obesity. J Obes, 2013. 2013: p. 348249.
  • Bell, C.N., J. Kerr, and J.L. Young, Associations between Obesity, Obesogenic Environments, and Structural Racism Vary by County-Level Racial Composition. Int J Environ Res Public Health, 2019. 16(5).
  • Suglia, S.F., et al., Why the Neighborhood Social Environment Is Critical in Obesity Prevention. J Urban Health, 2016. 93(1): p. 206-12.
  • Finucane, M.M., et al., National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet, 2011. 377(9765): p. 557-67.
  • Cheng, J., et al., The comprehensive summary of surgical versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. Oncotarget, 2016. 7(26): p. 39216-39230.
  • Mathus-Vliegen, E.M., Obesity and the elderly. J Clin Gastroenterol, 2012. 46(7): p. 533-44.
  • Kelly, T., et al., Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond), 2008. 32(9): p. 1431-7.
  • Kramer, C.K., B. Zinman, and R. Retnakaran, Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med, 2013. 159(11): p. 758-69.
  • Ma, C., et al., Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ, 2017. 359: p. j4849.
  • Pearl, R.L., et al., Short- and Long-Term Changes in Health-Related Quality of Life with Weight Loss: Results from a Randomized Controlled Trial. Obesity (Silver Spring), 2018. 26(6): p. 985-991.
  • Mendrick, D.L., et al., Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic. Toxicol Sci, 2018. 162(1): p. 36-42.
  • NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med, 1991. 115(12): p. 956-61.
  • Colquitt, J.L., et al., Surgery for weight loss in adults. Cochrane Database Syst Rev, 2014(8): p. CD003641.
  • le Roux, C.W. and H.M. Heneghan, Bariatric Surgery for Obesity. Med Clin North Am, 2018. 102(1): p. 165-182.
  • Pories, W.J., et al., Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg, 1995. 222(3): p. 339-50; discussion 350-2.
  • Billeter, A.T., et al., Meta-analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus. Br J Surg, 2018. 105(3): p. 168-181.
  • Yan, Y., et al., Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore), 2016. 95(17): p. e3462.
  • Guo, L., et al., [Body mass index and cancer incidence:a prospective cohort study in northern China]. Zhonghua Liu Xing Bing Xue Za Zhi, 2014. 35(3): p. 231-6.
  • Schiavon, C.A., et al., Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation, 2018. 137(11): p. 1132-1142.
  • Adams, T.D., et al., Weight and Metabolic Outcomes 12 Years after Gastric Bypass. N Engl J Med, 2017. 377(12): p. 1143-1155.
  • Mechanick, J.I., et al., Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring), 2013. 21 Suppl 1: p. S1-27.
  • Telem D. Greenstein AJ, W.B. Medical outcomes following bariatric surgery. 2018; Available from:
  • Ponce, J., et al., American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg Obes Relat Dis, 2016. 12(9): p. 1637-1639.
  • Arterburn, D.E. and A.P. Courcoulas, Bariatric surgery for obesity and metabolic conditions in adults. BMJ, 2014. 349: p. g3961.
  • Hanipah, Z.N. and P.R. Schauer, Surgical Treatment of Obesity and Diabetes. Gastrointest Endosc Clin N Am, 2017. 27(2): p. 191-211.
  • Gill, R.S., et al., The impact of bariatric surgery in patients with type-2 diabetes mellitus. Curr Diabetes Rev, 2011. 7(3): p. 185-9.
  • Cummings, D.E. and F. Rubino, Metabolic surgery for the treatment of type 2 diabetes in obese individuals. Diabetologia, 2018. 61(2): p. 257-264.
  • Koliaki, C., et al., The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC Endocr Disord, 2017. 17(1): p. 50.
  • 30. Akcay, M.N., E. Karadeniz, and A. Ahiskalioglu, Bariatric/Metabolic Surgery in Type 1 and Type 2 Diabetes Mellitus. Eurasian J Med, 2019. 51(1): p. 85-89.
  • Ashrafian, H., et al., Type 1 Diabetes Mellitus and Bariatric Surgery: A Systematic Review and Meta-Analysis. Obes Surg, 2016. 26(8): p. 1697-704.
  • Hussain, A., The effect of metabolic surgery on type 1 diabetes: meta-analysis. Arch Endocrinol Metab, 2018. 62(2): p. 172-178.
  • Cohen, R.V., et al., Diabetes remission without weight loss after duodenal bypass surgery. Surg Obes Relat Dis, 2012. 8(5): p. e66-8.
  • Cohen, R., P.P. Caravatto, and T.Z. Petry, Innovative metabolic operations. Surg Obes Relat Dis, 2016. 12(6): p. 1247-55.
  • Astiarraga, B., et al., Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. J Clin Endocrinol Metab, 2013. 98(7): p. 2765-73.
  • Coelho, D., et al., Diabetes Remission Rate in Different Bmi Grades Following Roux-En-Y Gastric Bypass. Arq Bras Cir Dig, 2018. 31(1): p. e1343.
  • Dong, Z., et al., Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis. BMC Surg, 2018. 18(1): p. 73.
  • Menzo, E.L., et al., American Society for Metabolic and Bariatric Surgery and American Hernia Society consensus guideline on bariatric surgery and hernia surgery. Surg Obes Relat Dis, 2018. 14(9): p. 1221-1232.
  • Bhandari, M., et al., Standardization of Bariatric Metabolic Procedures: World Consensus Meeting Statement. Obes Surg, 2019. 29(Suppl 4): p. 309-345.
  • Ryan, D.H. and S. Kahan, Guideline Recommendations for Obesity Management. Med Clin North Am, 2018. 102(1): p. 49-63.
  • Brito, J.P., V.M. Montori, and A.M. Davis, Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. JAMA, 2017. 317(6): p. 635-636.
  • Sabench Pereferrer, F., et al., Quality criteria in bariatric surgery: Consensus review and recommendations of the Spanish Association of Surgeons and the Spanish Society of Bariatric Surgery. Cir Esp, 2017. 95(1): p. 4-16.
  • Lecube, A., et al., Prevention, diagnosis, and treatment of obesity. 2016 position statement of the Spanish Society for the Study of Obesity. Endocrinol Diabetes Nutr, 2017. 64 Suppl 1: p. 15-22.
  • Vilallonga, R., et al., A Spanish Society joint SECO and SEEDO approach to the Post-operative management of the patients undergoing surgery for obesity. Obes Surg, 2019.
  • Busetto, L., et al., Obesity Management Task Force of the European Association for the Study of Obesity Released "Practical Recommendations for the Post-Bariatric Surgery Medical Management". Obes Surg, 2018. 28(7): p. 2117-2121.
  • Fried, M., et al., Interdisciplinary European Guidelines on metabolic and bariatric surgery. Obes Facts, 2013. 6(5): p. 449-68.
  • Vargas, E.J., et al., Medical Devices for Obesity Treatment: Endoscopic Bariatric Therapies. Med Clin North Am, 2018. 102(1): p. 149-163.
  • Espinet Coll, E., et al., Spanish Consensus Document on Bariatric Endoscopy. Part 1. General considerations. Rev Esp Enferm Dig, 2018. 110(6): p. 386-399.
  • Li, S.H., Y.J. Wang, and S.T. Zhang, Development of Bariatric and Metabolic Endoscopy. Chin Med J (Engl), 2018. 131(1): p. 88-94.
  • Ruban, A., et al., Medical Devices in Obesity Treatment. Curr Diab Rep, 2019. 19(10): p. 90.
  • Hill, C., et al., Endoluminal weight loss and metabolic therapies: current and future techniques. Ann N Y Acad Sci, 2018. 1411(1): p. 36-52.
  • Storm, A.C. and C.C. Thompson, Endoscopic Treatments Following Bariatric Surgery. Gastrointest Endosc Clin N Am, 2017. 27(2): p. 233-244.
  • Glaysher, M.A., et al., A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. BMJ Open, 2017. 7(11): p. e018598.
  • Peterli, R., et al., Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg, 2012. 22(5): p. 740-8.
  • Roth, C.L., et al., Ghrelin and obestatin levels in severely obese women before and after weight loss after Roux-en-Y gastric bypass surgery. Obes Surg, 2009. 19(1): p. 29-35.
  • Cazzo, E., et al., GLP-1 and GLP-2 Levels are Correlated with Satiety Regulation After Roux-en-Y Gastric Bypass: Results of an Exploratory Prospective Study. Obes Surg, 2017. 27(3): p. 703-708.
  • Svane, M.S., et al., Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery. Int J Obes (Lond), 2016. 40(11): p. 1699-1706.
  • Goldstone, A.P., et al., Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity. J Clin Endocrinol Metab, 2016. 101(2): p. 599-609.
  • Crujeiras, A.B., et al., Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress? Int J Obes (Lond), 2017. 41(10): p. 1570-1578.
  • Ejarque, M., et al., Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery. Transl Res, 2017. 184: p. 35-44 e4.
  • Krist, J., et al., Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts, 2013. 6(1): p. 57-69.
  • Hallberg, S.J., et al., Reversing Type 2 Diabetes: A Narrative Review of the Evidence. Nutrients, 2019. 11(4).
  • Bueter, M., et al., Renal cytokines improve early after bariatric surgery. Br J Surg, 2010. 97(12): p. 1838-44.
  • Balsa, J.A., et al., The role of serum osteoprotegerin and receptor-activator of nuclear factor-kappaB ligand in metabolic bone disease of women after obesity surgery. J Bone Miner Metab, 2016. 34(6): p. 655-661.
  • Gagnon, C. and A.L. Schafer, Bone Health After Bariatric Surgery. JBMR Plus, 2018. 2(3): p. 121-133.
  • Liu, H., et al., Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes. J Diabetes Investig, 2018. 9(1): p. 13-20.
  • Wang, W., et al., Role of Bile Acids in Bariatric Surgery. Front Physiol, 2019. 10: p. 374.
  • Rao, R.S., Bariatric surgery and the central nervous system. Obes Surg, 2012. 22(6): p. 967-78.
  • Berthoud, H.R., A.C. Shin, and H. Zheng, Obesity surgery and gut-brain communication. Physiol Behav, 2011. 105(1): p. 106-19.
  • Camastra, S., et al., Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery. Sci Rep, 2017. 7(1): p. 9007.
  • Chabot, K., et al., Evolution of subcutaneous adipose tissue fibrosis after bariatric surgery. Diabetes Metab, 2017. 43(2): p. 125-133.
  • du Plessis, J., et al., Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology, 2015. 149(3): p. 635-48 e14.
  • Spoto, B., et al., Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity. Nutr Metab Cardiovasc Dis, 2014. 24(10): p. 1137-43.
  • Chasapi, A., et al., Can obesity-induced inflammation in skeletal muscle and intramuscular adipose tissue accurately detect liver fibrosis? J Musculoskelet Neuronal Interact, 2018. 18(4): p. 509-524.
  • Saafan, T., W. El Ansari, and M. Bashah, Compared to What? Is BMI Associated with Histopathological Changes in Laparoscopic Sleeve Gastrectomy Specimens? Obes Surg, 2019. 29(7): p. 2166-2173.
  • Nogueira Tde, B., et al., H. pylori infection, endoscopic, histological aspects and cell proliferation in the gastric mucosa of patients submitted to roux-en-y gastric bypass with contention ring: a cross sectional endoscopic and immunohistochemical study. Arq Gastroenterol, 2016. 53(1): p. 55-60.
  • Rumilla, K.M., et al., Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression. Mod Pathol, 2009. 22(2): p. 239-45.
  • Service, G.J., et al., Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med, 2005. 353(3): p. 249-54.
  • Rubino, F., Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care, 2008. 31 Suppl 2: p. S290-6.
  • Rubino, F. and J. Marescaux, Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg, 2004. 239(1): p. 1-11.
  • Rubino, F., et al., The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg, 2006. 244(5): p. 741-9.
  • Camacho-Ramirez, A., et al., Bariatric surgery influences beta-cell turnover in non obese rats. Histol Histopathol, 2017. 32(12): p. 1341-1350.
  • Shimizu, H., et al., The effect of selective gut stimulation on glucose metabolism after gastric bypass in the Zucker diabetic fatty rat model. Surg Obes Relat Dis, 2014. 10(1): p. 29-35.
  • Salinari, S., et al., Duodenal-jejunal bypass and jejunectomy improve insulin sensitivity in Goto-Kakizaki diabetic rats without changes in incretins or insulin secretion. Diabetes, 2014. 63(3): p. 1069-78.
  • Prada-Oliveira, J.A., et al., GLP-1 mediated improvement of the glucose tolerance in the T2DM GK rat model after massive jejunal resection. Ann Anat, 2019. 223: p. 1-7.
  • Camacho-Ramirez, A., et al., The histomorphometric parameters of endocrine pancreas after bariatric surgery in healthy animal models. Tissue Cell, 2019. 57: p. 78-83.
  • Moreno-Arciniegas, A., et al., The main participation of the enterohormone GLP-1 after bariatric surgery. Minerva Chir, 2019. 74(1): p. 7-13.
  • Grong, E., et al., Sleeve gastrectomy, but not duodenojejunostomy, preserves total beta-cell mass in Goto-Kakizaki rats evaluated by three-dimensional optical projection tomography. Surg Endosc, 2016. 30(2): p. 532-542.
  • Sharkey, K.A., Animal models of bariatric/metabolic surgery shed light on the mechanisms of weight control and glucose homeostasis: view from the chair. Int J Obes (Lond), 2011. 35 Suppl 3: p. S31-4.
  • Perez-Arana, G., et al., A surgical model of short bowel syndrome induces a long-lasting increase in pancreatic beta-cell mass. Histol Histopathol, 2015. 30(4): p. 479-87.